Home › Funds › Blue Whale Capital LLP › RGEN

Blue Whale Capital LLP position in RGEN

Repligen Corp · Health Care

Blue Whale Capital LLP reported holding 146,210 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$28.1M, representing 0.88% of its reported portfolio and ranking #21 among its reported holdings. Blue Whale Capital LLP has disclosed RGEN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)146.21K sh
Reported value held$28.11M
Portfolio Weight0.88%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Whale Capital LLP's RGEN position evolved

Blue Whale Capital LLP first disclosed a stake in RGEN in Q2 2025 at 287,686 shares (US$35.8M). The position peaked in Q4 2025 at 308,467 shares, worth US$50.5M. Across 6 filings, Blue Whale Capital LLP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 146,210 shares valued at US$28.1M — a reduction of -32,167 shares quarter over quarter.. Notable position changes include a 27% increase in Q4 2025 (shares fell 28% over the following quarter), a 31% increase in Q1 2026 (shares rose 16% over the following quarter), a 56% trim in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 287.69K $35.78M New
Q3 2025 243.10K $32.50M Reduce
Q4 2025 308.47K $50.55M Add
Q1 2026 404.20K $47.62M Add
Q2 2026 178.38K $24.34M Reduce
Q3 2026 146.21K $28.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has Blue Whale Capital LLP held RGEN?

Blue Whale Capital LLP has disclosed RGEN holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Blue Whale Capital LLP's current position in RGEN?

As of Q3 2026, Blue Whale Capital LLP holds 146.21K shares of RGEN (Repligen Corp), valued at $28.11M, representing 0.88% of its reported portfolio and ranking #21.

Has Blue Whale Capital LLP been buying or selling RGEN?

In the latest 13F filing (Q3 2026), Blue Whale Capital LLP reduced its position in RGEN. The position peaked in Q4 2025 at 308.47K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.